Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease

Conditions

• Gaucher Disease, Type 1
• Cerebroside Lipidosis Syndrome
• Glucocerebrosidase Deficiency Disease
• Glucosylceramide Beta-Glucosidase Deficiency Disease
• Gaucher Disease, Non-Neuronopathic Form

Interventions

• DRUG: Cerezyme

Sponsor

Genzyme, a Sanofi Company